.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Indiva’s mix in August 2026 is fully concentrated in Capsules at 100.0% share, with category sales down 52.28% year over year and 15.04% month over month, while brand-level sales declined 53.81% year over year and the average price rose 33.58% year over year. Within this single-category focus, Capsules averaged $32.84 and posted a sharper month-over-month contraction of 15.04% against a broader two-year brand sales decline of 69.21%, implying that Indiva’s one-category dependency is amplifying volatility rather than distributing risk.
The all-in bet on Capsules aligns with a rank of 3 in Capsules in British Columbia, yet a 15.04% month-over-month drop alongside a 52.28% year-over-year category contraction signals that the positioning is tilted toward defending share in a shrinking lane rather than building breadth. With 100.0% of sales tied to Capsules and average pricing at $32.84 amid a 33.58% year-over-year price increase, Indiva’s stance implies near-term margin defense at the expense of demand elasticity, leaving the brand’s positioning vulnerable to further rank erosion if category declines persist.
Competitive Landscape
Indiva sits at rank #6 in ON Capsules in August 2026, unchanged from #6 year over year, and flat versus the last three months at #6, while its historical peak was #5 in June 2025. In contrast, Glacial Gold advanced from #4 to #2 with a 43.3% YoY sales increase, and Emprise Canada climbed from #5 to #3 with 61.4% YoY growth, whereas Redecan fell from #2 to #5 alongside a 41.1% YoY sales decline. This mix of upward mobility among challengers and rank slippage among incumbents indicates Indiva’s static #6 position risks entrenchment unless it captures share from rising mid-pack movers.
Notable Products
CBG/THC 1:2 Blips Tablets 20-Pack (100mg CBG, 200mg THC) posted the steepest decline at -45.7% MoM and slid outside the top three while Big Blips THC Tablets 55-Pack (550mg) fell -15.3% and held rank 1. Blips THC Tablets 25-Pack (250mg) dropped -11.3% at rank 2, putting two falling leaders ahead of a faster-shrinking specialty SKU and concentrating power in Capsules, which account for all three ranked positions. With Capsules occupying ranks 1 through 3 but all posting double-digit MoM declines, the mix implies an overreliance on tablet formats that is losing velocity and needs either pricing or innovation to rebalance demand.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
